Ilika plc Appoint Keith Jackson as Chairman and form Technology Advisory Board

Ilika plc

Ilika plc (LON: IKA), the advanced solid-state battery technology company, announced today the appointment of Keith Jackson as Chairman from the 1st January 2019, when Mike Inglis will step down from the Board.

Keith Jackson has been a Non-Executive Director of Ilika since 2014 and is also currently Chief Technology Officer at Meggitt plc, where he is responsible for technology direction and strategy. Keith has had a wide-ranging and successful career in companies varying from start-ups to multinationals. He founded and as CEO grew automotive control systems company Pi Technology. Following the successful sale of the company to Ford, he joined Rolls Royce plc and became Chief Technology Officer in the electrical power and control systems group. Keith is a Fellow of the Society of Automotive Engineers and is a graduate from University College London.

Mike Inglis was appointed a Non-Executive Director of Ilika in July 2015 and Chairman in September 2015. He has chosen the completion of a three-year period as Chairman to step down for capacity reasons following increased committee activities on his other boards. Mike will remain involved with Ilika and become the founding member of Ilika’s Technology Advisory Board, a team of industry experts to advise on the commercialisation of Ilika’s technology with specialist sector knowledge.

Graeme Purdy, Ilika plc CEO, stated:

“We are very grateful to Mike for the direction he has given the Ilika board over the past three years. He has assisted greatly in setting up the commercial framework we have established for bringing our Stereaxâ technology to market. I am delighted that Mike has agreed to be the founding member of Ilika’s Technology Advisory Board, which will be used to contribute to Ilika’s strategic direction in the coming years.”

Mike Inglis, Chairman, added:

“I have been impressed with the commercial and technical progress achieved by Ilika during my period as Chairman and I am pleased to hand over to Keith, who provides strategic continuity and brings a wealth of commercial experience, international technology and manufacturing experience to guide Ilika in its next phase.”

Keith Jackson, Chairman elect, added:

“I am delighted to accept the opportunity to guide Ilika’s board as we take the Company into its next phase of commercial exploitation.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Defence battery demand highlights a practical growth opportunity

Defence applications are increasing the need for safer, lighter and more reliable battery technology.

Ilika raises ÂŁ4.56m in oversubscribed placing and subscription

Ilika has conditionally raised approximately ÂŁ4.56 million through an oversubscribed placing and subscription, with proceeds to support the commercialisation of its Stereax and Goliath solid-state battery technologies.

Ilika launches Retail Offer to raise up to ÂŁ0.5 Million

Ilika has opened a UK retail offer via BookBuild to raise up to £0.5 million, alongside a £4.56 million placing and directors’ subscription. Proceeds will support the commercial rollout of Stereax technology and further development of the Goliath battery programme.

Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Search